Stroke - Sleep Disorders, Dysfunction of the Autonomic Nervous System and Depression
Studieoversikt
Status
Forhold
Detaljert beskrivelse
Up to fifty percent of stroke patients suffer less noticeable comorbidities after the acute phase of a stroke and often the rest of their life. It concerns sleep disordered breathing (SDB), post stroke depression (PSD), and dysfunction of the autonomic nervous system. These comorbidities are seldom recognized, but are associated with a poorer outcome after stroke, reduced quality of life as well as an increased risk of new vascular events.
Little is known about the course of the comorbidities, the relationship between the mentioned diseases or which patients are more commonly affected.
The investigators will investigate the following hypotheses, and assess the results compared to the stroke aetiology:
- Stroke patients with SDB have an impaired autonomic function
- Stroke patients with SDB have an increased risk of PSD
- Stroke patients with autonomic dysfunction have an increased risk of PSD
The investigators will examine stroke patients for signs of sleep disordered breathing, autonomic dysfunction and depression, both in the acute phase (days), in the chronic phase (months) and the very chronic state (years). Thereby the investigators can map the comorbidities course over time. At the same time the patients will be tested for peripheral small and large artery disease as well as MRI will be used to investigate sign of cerebral small vessel disease.
Based on power calculations 335 individuals will be enrolled in order to satisfy the project requirements.
Studietype
Registrering (Faktiske)
Kontakter og plasseringer
Studiesteder
-
-
-
Glostrup, Danmark, 2600
- Department of clinical stroke research, department of neurology, Glostrup Hospital
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
• Clinical stroke either ischaemic or haemorrhagic
Exclusion Criteria:
- Transitory ischemic attac
- Congenital or acquired brain disease, other than stroke
- Dementia
- Mental retardation
- Fatal stroke or severe comorbidities with short expected life
- Pregnancy or breastfeeding
- Altered consciousness e.g. delirium or status epilepticus
- Other cause of the patient, according to the investigator believes, can not complete the study
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Observasjonsmodeller: Kohort
- Tidsperspektiver: Potensielle
Kohorter og intervensjoner
Gruppe / Kohort |
|---|
|
Acute stroke
No interventions.
Only tests for depression, sleepapnea and autonomic dysfunction.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Sleep disordered breathing at any time after stroke.
Tidsramme: six month after stroke
|
The test for sleep disordered breathing will be performed within 7 days from stroke onset and after 6 month and five years. Mild sleep apnea if AHI between 5 and 15, moderate sleep apnea if AHI between 15 and 30 and severe sleep apnea if AHI above 30. Subdivided into obstructive, central or mixed. |
six month after stroke
|
|
Autonomic dysfunction at any time after stroke.
Tidsramme: six month after the stroke
|
The test for autonomic dysfunction will be performed within 7 days from stroke onset and after 6 month and five years. Abnormal result of the valsalva manoeuvre, deep breathing, active standing or tilt table test. Improvement or worsening of the parameters like HRV, BRS and CO during the study period. |
six month after the stroke
|
|
Depression at any time after stroke
Tidsramme: six month after the stroke
|
The test for depression will be performed within 7 days from stroke onset and after 6 month and five years. Mild, moderate or severe depression according to HAM-D6, MDI or HADS |
six month after the stroke
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Peripheral artery disease at any time after stroke
Tidsramme: six month after the stroke
|
The tests will be performed within 7 days from stroke onset and after 6 month and five years. Stenosis of the carotid artery, abnormal ankle-brachial index or endothelial dysfunction. |
six month after the stroke
|
Andre resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
New vascular episodes at any time after stroke
Tidsramme: Assessed at follow-up after six month
|
Assessed at follow-up after six month and five years.
Stroke, TIA, acute coronary syndrome or operation for peripheral vascular disease.
|
Assessed at follow-up after six month
|
|
Death by cause at any time after stroke
Tidsramme: Assessed at follow-up after six month
|
Assessed at follow-up after six month and five years
|
Assessed at follow-up after six month
|
Samarbeidspartnere og etterforskere
Etterforskere
- Hovedetterforsker: Helle Iversen, MD, DMSc, Stroke research, Glostrup hospital
Publikasjoner og nyttige lenker
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- VEK: H-2-3013-091
- H-2-3013-091 (Annen identifikator: Research Ethics Committee)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .